Platelet-Rich Plasma in Orthopaedic Surgery and Sports Medicine: Pearls, Pitfalls, and New Trends in Research

Operative Techniques in Orthopaedics

Volumn 22, Issue 2, 2012, Pages 91-103

  Steinert, Andre F ^a   Middleton, Kellie K ^b   Araujo, Paulo H ^b   Fu, Freddie H ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Orthopaedic surgery; Platelet rich plasma; Tissue regeneration

Indexed keywords

FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN; THROMBOCYTE FACTOR 4; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ACHILLES TENDON RUPTURE; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTICLE; BIOCHEMICAL COMPOSITION; CARTILAGE DEGENERATION; CLINICAL EFFECTIVENESS; DISTRACTION OSTEOGENESIS; FRACTURE NONUNION; HUMAN; LIGAMENT INJURY; MEDICAL RESEARCH; MUSCLE INJURY; NONHUMAN; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN SECRETION; RANGE OF MOTION; RISK ASSESSMENT; ROTATOR CUFF INJURY; SPINE FUSION; SPORTS MEDICINE; TENDINITIS; THERAPY EFFECT; THROMBOCYTE RICH PLASMA; TREATMENT PLANNING; TREND STUDY; WOUND HEALING;

EID: 84861499475     PISSN: 10486666     EISSN: 15583848     Source Type: Journal    
DOI: 10.1053/j.oto.2011.10.004     Document Type: Article

References (114)

1. Knighton D.R., Hunt T.K., Thakral K.K., et al. Role of platelets and fibrin in the healing sequence: An in vivo study of angiogenesis and collagen synthesis. Ann Surg 1982, 196:379-388.
2. Foster T.E., Puskas B.L., Mandelbaum B.R., et al. Platelet-rich plasma: From basic science to clinical applications. Am J Sports Med 2009, 37:2259-2272.
3. Taylor D.W., Petrera M., Hendry M., et al. A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med 2011, 21:344-352.
4. Redler L.H., Thompson S.A., Hsu S.H., et al. Platelet-rich plasma therapy: A systematic literature review and evidence for clinical use. Phys Sportsmed 2011, 39:42-51.
5. de Vos R.J., van Veldhoven P.L., Moen M.H., et al. Autologous growth factor injections in chronic tendinopathy: A systematic review. Br Med Bull 2010, 95:63-77.
6. Mishra A., Harmon K., Woodall J., et al. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol 2011 Jul 8, (Epub ahead of print).
7. Everts P.A., Knape J.T., Weibrich G., et al. Platelet-rich plasma and platelet gel: A review. J Extra Corpor Technol 2006, 38:174-187.
8. Mehta S., Watson J.T. Platelet rich concentrate: Basic science and current clinical applications. J Orthop Trauma 2008, 22:432-438.
9. Wrotniak M., Bielecki T., Gazdzik T.S. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil 2007, 9:227-238.
10. Nikolidakis D., Jansen J.A. The biology of platelet-rich plasma and its application in oral surgery: Literature review. Tissue Eng Part B Rev 2008, 14:249-258.
11. Burnouf P.A., Juan P.K., Su C.Y., et al. A novel virally inactivated human platelet lysate preparation rich in TGF-beta, EGF and IGF, and depleted of PDGF and VEGF. Biotechnol Appl Biochem 2010, 56:151-160.
12. Alsousou J., Thompson M., Hulley P., et al. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: A review of the literature. J Bone Joint Surg Br 2009, 91:987-996.
13. Illingworth A.J., Musahl V., Lorenz S., et al. Use of fibrin clot in the knee. Operative techniques in orthopaedics. Oper Tech Orthop 2010, 20:90-97.
14. Arnoczky S.P. Building a meniscus. BioLogic considerations. Clin Orthop Relat Res 1999, S244-S253.
15. Evans C.H., Palmer G.D., Pascher A., et al. Facilitated endogenous repair: Making tissue engineering simple, practical, and economical. Tissue Eng 2007, 13:1987-1993.
16. Pascher A., Palmer G.D., Steinert A., et al. Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther 2004, 11:133-141.
17. Sánchez M., Anitua E., Andia I. Poor standardization in platelet-rich therapies hampers advancement. Arthroscopy 2010, 26:725-726. author reply 726.
18. Nöth U., Rackwitz L., Steinert A.F., et al. Cell delivery therapeutics for musculoskeletal regeneration. Adv Drug Deliv Rev 2010, 62:765-783.
19. Lopez-Vidriero E., Goulding K.A., Simon D.A., et al. The use of platelet-rich plasma in arthroscopy and sports medicine: Optimizing the healing environment. Arthroscopy 2010, 26:269-278.
20. Nin J.R., Gasque G.M., Azcárate A.V., et al. Has platelet-rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy 2009, 25:1206-1213.
21. Cervellin M., de Girolamo L., Bait C., et al. Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: A randomized, controlled clinical study. Knee Surg Sports Traumatol Arthrosc 2012, 20:114-120.
22. Silva A., Sampaio R. Anatomic ACL reconstruction: Does the platelet-rich plasma accelerate tendon healing?. Knee Surg Sports Traumatol Arthrosc 2009, 17:676-682.
23. Radice F., Yánez R., Gutiérrez V., et al. Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy 2010, 26:50-57.
24. Vogrin M., Rupreht M., Dinevski D., et al. Effects of a platelet gel on early graft revascularization after anterior cruciate ligament reconstruction: A prospective, randomized, double-blind, clinical trial. Eur Surg Res 2010, 45:77-85.
25. Vogrin M., Rupreht M., Crnjac A., et al. The effect of platelet-derived growth factors on knee stability after anterior cruciate ligament reconstruction: A prospective randomized clinical study. Wien Klin Wochenschr 2010, 122(suppl 2):91-95.
26. Orrego M., Larrain C., Rosales J., et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy 2008, 24:1373-1380.
27. Sánchez M., Anitua E., Azofra J., et al. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: Gross morphology and histology. Arthroscopy 2010, 26:470-480.
28. Sánchez M., Anitua E., Lopez-Vidriero E., et al. The future: Optimizing the healing environment in anterior cruciate ligament reconstruction. Sports Med Arthrosc 2010, 18:48-53.
29. Sánchez M., Anitua E., Azofra J., et al. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007, 35:245-251.
30. Randelli P.S., Arrigoni P., Cabitza P., et al. Autologous platelet rich plasma for arthroscopic rotator cuff repair: A pilot study. Disabil Rehabil 2008, 30:1584-1589.
31. Randelli P., Arrigoni P., Ragone V., et al. Platelet rich plasma in arthroscopic rotator cuff repair: A prospective RCT study, 2-year follow-up. J Shoulder Elbow Surg 2011, 20:518-528.
32. Castricini R., Longo U.G., De Benedetto M., et al. Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: A randomized controlled trial. Am J Sports Med 2011, 39:258-265.
33. Jo C.H., Kim J.E., Yoon K.S., et al. Does platelet-rich plasma accelerate recovery after rotator cuff repair?. A prospective cohort study. Am J Sports Med 2011, 39:2082-2090.
34. Barber F.A., Hrnack S.A., Snyder S.J., et al. Rotator cuff repair healing influenced by platelet-rich plasma construct augmentation. Arthroscopy 2011, 27:1029-1035.
35. Everts P.A., Devilee R.J., Brown Mahoney C., et al. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double-blind study. Eur Surg Res 2008, 40:203-210.
36. Kon E., Filardo G., Delcogliano M., et al. Platelet-rich plasma: New clinical application: A pilot study for treatment of jumper's knee. Injury 2009, 40:598-603.
37. Clarke A.W., Alyas F., Morris T., et al. Skin-derived tenocyte-like cells for the treatment of patellar tendinopathy. Am J Sports Med 2011, 39:614-623.
38. de Vos R.J., Weir A., van Schie H.T., et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA 2010, 303:144-149.
39. Mishra A., Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006, 34:1774-1778.
40. Hechtman K.S., Uribe J.W., Botto-van D.A., et al. Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis. Orthopaedics 2011, 34:92.
41. Peerbooms J.C., Sluimer J., Bruijn D.J., et al. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: Platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 2010, 38:255-262.
42. Thanasas C., Papadimitriou G., Charalambidis C., et al. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: A randomized controlled clinical trial. Am J Sports Med 2011, 39:2130-2134.
43. Wright-Carpenter T., Klein P., Schäferhoff P., et al. Treatment of muscle injuries by local administration of autologous conditioned serum: A pilot study on sportsmen with muscle strains. Int J Sports Med 2004, 25:588-593.
44. Hamilton B.H., Best T.M. Platelet-enriched plasma and muscle strain injuries: Challenges imposed by the burden of proof. Clin J Sport Med 2011, 21:31-36.
45. Sampson S., Reed M., Silvers H., et al. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: A pilot study. Am J Phys Med Rehabil 2010, 89:961-969.
46. Sanchez M., Anitua E., Azofra J., et al. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: A retrospective cohort study. Clin Exp Rheumatol 2008, 26:910-913.
47. Kon E., Buda R., Filardo G., et al. Platelet-rich plasma: Intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2010, 18:472-479.
48. Filardo G., Kon E., Buda R., et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2011, 19:528-535.
49. Baltzer A.W., Moser C., Jansen S.A., et al. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage 2009, 17:152-160.
50. Gardner M.J., Demetrakopoulos D., Klepchick P.R., et al. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop 2007, 31:309-313.
51. Everts P.A., Devilee R.J., Oosterbos C.J., et al. Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: Improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc 2007, 15:888-894.
52. Horstmann W.G., Slappendel R., van Hellemondt G.G., et al. Autologous platelet gel in total knee arthroplasty: A prospective randomized study. Knee Surg Sports Traumatol Arthrosc 2011, 19:115-121.
53. Zavadil D.P., Satterlee C.C., Costigan J.M., et al. Autologous platelet gel and platelet-poor plasma reduce pain with total shoulder arthroplasty. J Extra Corpor Technol 2007, 39:177-182.
54. Calori G.M., Tagliabue L., Gala L., et al. Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: A prospective randomised clinical study on 120 patients. Injury 2008, 39:1391-1402.
55. Lowery G.L., Kulkarni S., Pennisi A.E. Use of autologous growth factors in lumbar spinal fusion. Bone 1999, 25:47S-50S.
56. Weiner B.K., Walker M. Efficacy of autologous growth factors in lumbar intertransverse fusions. Spine (Phila PA 1976) 2003, 28:1968-1970. discussion 1971.
57. Jenis L.G., Banco R.J., Kwon B. A prospective study of Autologous Growth Factors (AGF) in lumbar interbody fusion. Spine J 2006, 6:14-20.
58. Sys J., Weyler J., Van Der Zijden T., et al. Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion. Eur Spine J 2011, 20:1650-1657.
59. Kitoh H., Kitakoji T., Tsuchiya H., et al. Distraction osteogenesis of the lower extremity in patients with achondroplasia/hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma. J Pediatr Orthop 2007, 27:629-634.
60. Kitoh H., Kitakoji T., Tsuchiya H., et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis-A preliminary result of three cases. Bone 2004, 35:892-898.
61. Kitoh H., Kitakoji T., Tsuchiya H., et al. Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone 2007, 40:522-528.
62. Kazakos K., Lyras D.N., Verettas D., et al. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury 2009, 40:801-805.
63. Guo Y., Qiu J., Zhang C. Follow-up study on platelet-rich plasma in repairing chronic wound nonunion of lower limbs in 47 cases [in Chinese]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2008, 22:1301-1305.
64. Calori G.M., D'Avino M., Tagliabue L., et al. An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: Protocol description and preliminary results. Injury 2006, 37(suppl 3):S43-S50.
65. Choi B.H., Zhu S.J., Kim B.Y., et al. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: An in vitro study. Int J Oral Maxillofac Surg 2005, 34:420-424.
66. Graziani F., Ivanovski S., Cei S., et al. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 2006, 17:212-219.
67. Cheng M., Wang H., Yoshida R., et al. Platelets and plasma proteins are both required to stimulate collagen gene expression by anterior cruciate ligament cells in three-dimensional culture. Tissue Eng Part A 2010, 16:1479-1489.
68. Mastrangelo A.N., Vavken P., Fleming B.C., et al. Reduced platelet concentration does not harm PRP effectiveness for ACL repair in a porcine in vivo model. J Orthop Res 2011, 29:1002-1007.
69. Weibrich G., Hansen T., Kleis W., et al. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 2004, 34:665-671.
70. Andia I., Sanchez M., Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther 2010, 10:1415-1426.
71. Nguyen R.T., Borg-Stein J., McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: An evidence-based approach. PM R 2011, 3:226-250.
72. Sampson S., Gerhardt M., Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: A review. Curr Rev Musculoskelet Med 2008, 1:165-174.
73. Castillo T.N., Pouliot M.A., Kim H.J., et al. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med 2011, 39:266-271.
74. Stief M., Gottschalk J., Ionita J.C., et al. Concentration of platelets and growth factors in canine autologous conditioned plasma. Vet Comp Orthop Traumatol 2011, 24:122-125.
75. Paoloni J., De Vos R.J., Hamilton B., et al. Platelet-rich plasma treatment for ligament and tendon injuries. Clin J Sport Med 2011, 21:37-45.
76. Kon E., Filardo G., Di Martino A., et al. Platelet-rich plasma (PRP) to treat sports injuries: Evidence to support its use. Knee Surg Sports Traumatol Arthrosc 2011, 19:516-527.
77. Lacci K.M., Dardik A. Platelet-rich plasma: Support for its use in wound healing. Yale J Biol Med 2010, 83:1-9.
78. Everts P.A., Hoffmann J., Weibrich G., et al. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus Med 2006, 16:363-368.
79. Anitua E., Sánchez M., Orive G., et al. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007, 28:4551-4560.
80. Landesberg R., Burke A., Pinsky D., et al. Activation of platelet-rich plasma using thrombin receptor agonist peptide. J Oral Maxillofac Surg 2005, 63:529-535.
81. Vavken P., Sadoghi P., Murray M.M. The effect of platelet concentrates on graft maturation and graft-bone interface healing in anterior cruciate ligament reconstruction in human patients: A systematic review of controlled trials. Arthroscopy 2011, 27:573-583.
82. Bibbo C., Hatfield P.S. Platelet-rich plasma concentrate to augment bone fusion. Foot Ankle Clin 2010, 15:641-649.
83. Hildner F., Albrecht C., Gabriel C., et al. State of the art and future perspectives of articular cartilage regeneration: A focus on adipose-derived stem cells and platelet-derived products. J Tissue Eng Regen Med 2011, 5:e36-e51.
84. Andia I., Sánchez M., Maffulli N. Platelet rich plasma therapies for sports muscle injuries: Any evidence behind clinical practice?. Expert Opin Biol Ther 2011, 11:509-518.
85. Mei-Dan O., Lippi G., Sanchez M., et al. Autologous platelet-rich plasma: A revolution in soft tissue sports injury management?. Phys Sportsmed 2010, 38:127-135.
86. Mishra A., Woodall J., Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med 2009, 28:113-125.
87. Spindler K.P., Murray M.M., Carey J.L., et al. The use of platelets to affect functional healing of an anterior cruciate ligament (ACL) autograft in a caprine ACL reconstruction model. J Orthop Res 2009, 27:631-638.
88. Murray M.M., Palmer M., Abreu E., et al. Platelet-rich plasma alone is not sufficient to enhance suture repair of the ACL in skeletally immature animals: An in vivo study. J Orthop Res 2009, 27:639-645.
89. Murray M.M., Spindler K.P., Abreu E., et al. Collagen-platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament. J Orthop Res 2007, 25:81-91.
90. Aspenberg P. Stimulation of tendon repair: Mechanical loading, GDFs and platelets: A mini-review. Int Orthop 2007, 31:783-789.
91. Anitua E., Sánchez M., Orive G., et al. Shedding light in the controversial terminology for platelet rich products. J Biomed Mater Res A 2009, 90:1262-1263.
92. De Carli A., Volpi P., Pelosini I., et al. New therapeutic approaches for management of sport-induced muscle strains. Adv Ther 2009, 26:1072-1083.
93. Wright-Carpenter T., Opolon P., Appell H.J., et al. Treatment of muscle injuries by local administration of autologous conditioned serum: A pilot study on sportsmen with muscle strains. Int J Sports Med 2004, 25:588-593.
94. Hammond J.W., Hinton R.Y., Curl L.A., et al. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med 2009, 37:1135-1142.
95. Buckwalter J.A., Saltzman C., Brown T. The impact of osteoarthritis: Implications for research. Clin Orthop Relat Res 2004, (suppl 427):S6-S15.
96. Steinert A.F., Ghivizzani S.C., Rethwilm A., et al. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther 2007, 9:213.
97. Jüni P., Reichenbach S., Trelle S., et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: A randomized controlled trial. Arthritis Rheum 2007, 56:3610-3619.
98. Abate M., Pulcini D., Di Iorio A., et al. Viscosupplementation with intra-articular hyaluronic acid for treatment of osteoarthritis in the elderly. Curr Pharm Des 2010, 16:631-640.
99. Waddell D.D., Bert J.M. The use of hyaluronan after arthroscopic surgery of the knee. Arthroscopy 2010, 26:105-111.
100. Huskin J.P., Vandekerckhove B., Delincé P., et al. Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy. Knee Surg Sports Traumatol Arthrosc 2008, 16:747-752.
101. Goldberg V.M., Buckwalter J.A. Hyaluronans in the treatment of osteoarthritis of the knee: Evidence for disease-modifying activity. Osteoarthritis Cartilage 2005, 13:216-224.
102. Bellamy N., Campbell J., Robinson V., et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005, CD005321.
103. Soomekh D.J. Current concepts for the use of platelet-rich plasma in the foot and ankle. Clin Podiatr Med Surg 2011, 28:155-170.
104. Anitua E., Andia I., Ardanza B., et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91:4-15.
105. Anitua E.A. Enhancement of osseointegration by generating a dynamic implant surface. J Oral Implantol 2006, 32:72-76.
106. Anitua E. The use of plasma-rich growth factors (PRGF) in oral surgery. Pract Proced Aesthet Dent 2001, 13:487-493. quiz 487-493.
107. Marx R.E., Carlson E.R., Eichstaedt R.M., et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85:638-646.
108. Anitua E., Sánchez M., Nurden A.T., et al. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006, 24:227-234.
109. Anitua E., Sánchez M., Orive G., et al. Delivering growth factors for therapeutics. Trends Pharmacol Sci 2008, 29:37-41.
110. Sabharwal S. Enhancement of bone formation during distraction osteogenesis: Pediatric applications. J Am Acad Orthop Surg 2011, 19:101-111.
111. Gandhi A., Bibbo C., Pinzur M., et al. The role of platelet-rich plasma in foot and ankle surgery. Foot Ankle Clin 2005, 10:621-637. viii.
112. Mazzucco L., Balbo V., Cattana E., et al. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang 2009, 97:110-118.
113. Mei-Dan O., Laver L., Nyska M., et al. Platelet rich plasma-a new biotechnology for treatment of sports injuries [in Hebrew]. Harefuah 2011, 150:453-457. 490.
114. Gandhi A., Doumas C., O'Connor J.P., et al. The effects of local platelet rich plasma delivery on diabetic fracture healing. Bone 2006, 38:540-546.